These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 21859943)

  • 21. Dapsone drug resistance in the MDT era.
    Roche PW; Neupane KD; Failbus SS; Butlin CR
    Int J Lepr Other Mycobact Dis; 2000 Sep; 68(3):323-5. PubMed ID: 11221097
    [No Abstract]   [Full Text] [Related]  

  • 22. Dapsone resistance in Mycobacterium leprae.
    Gillis TP; Williams DL
    Lepr Rev; 2000 Dec; 71 Suppl():S91-5. PubMed ID: 11201896
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Computational Modelling of Dapsone Interaction With Dihydropteroate Synthase in Mycobacterium leprae; Insights Into Molecular Basis of Dapsone Resistance in Leprosy.
    Chaitanya V S; Das M; Bhat P; Ebenezer M
    J Cell Biochem; 2015 Oct; 116(10):2293-303. PubMed ID: 25833404
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Emergence and Transmission of Drug-/Multidrug-resistant Mycobacterium leprae in a Former Leprosy Colony in the Brazilian Amazon.
    Rosa PS; D'Espindula HRS; Melo ACL; Fontes ANB; Finardi AJ; Belone AFF; Sartori BGC; Pires CAA; Soares CT; Marques FB; Branco FJD; Baptista IMFD; Trino LM; Fachin LRV; Xavier MB; Floriano MC; Ura S; Diório SM; Delanina WFB; Moraes MO; Virmond MCL; Suffys PN; Mira MT
    Clin Infect Dis; 2020 May; 70(10):2054-2061. PubMed ID: 31260522
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Committee 4: workshop on experimental chemotherapy of leprosy.
    Int J Lepr Other Mycobact Dis; 1979 Jun; 47(2 Suppl):297-303. PubMed ID: 378876
    [No Abstract]   [Full Text] [Related]  

  • 26. Ofloxacin resistance in multibacillary new leprosy cases from Purulia, West Bengal: a threat to effective secondary line treatment for rifampicin-resistant leprosy cases.
    Ahuja M; Singh I; Lavania M; Pathak VK; Darlong J; Turankar RP; Hembrom S; Singh SV; Sengupta U
    J Glob Antimicrob Resist; 2022 Sep; 30():282-285. PubMed ID: 35717020
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relapses in leprosy patients treated with rifampicin plus dapsone after varying periods of dapsone monotherapy.
    Li HY; Ran SP; Weng XM; Li TG; Deng XH; Li FT
    Indian J Lepr; 2001; 73(1):1-10. PubMed ID: 11326592
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Multi-drug resistant Mycobacterium leprae from patients with leprosy].
    Maeda S
    Nihon Hansenbyo Gakkai Zasshi; 2004 Sep; 73(3):227-33. PubMed ID: 15508725
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Screening of drugs for activity against Mycobacterium leprae.
    Baohong J; Matsuo Y; Colston MJ
    Int J Lepr Other Mycobact Dis; 1987 Dec; 55(4 Suppl):836-42. PubMed ID: 3325576
    [No Abstract]   [Full Text] [Related]  

  • 30. Molecular detection of multidrug-resistant Mycobacterium leprae from Indian leprosy patients.
    Lavania M; Singh I; Turankar RP; Ahuja M; Pathak V; Sengupta U; Das L; Kumar A; Darlong J; Nathan R; Maseey A
    J Glob Antimicrob Resist; 2018 Mar; 12():214-219. PubMed ID: 29097343
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Antibacterial chemotherapy in leprosy: principles, objectives and recommendations].
    Sansarricq H
    Acta Leprol; 1986; 4(3):355-62. PubMed ID: 3551474
    [No Abstract]   [Full Text] [Related]  

  • 32. Report of rpoB mutation in clinically suspected cases of drug resistant leprosy: a study from Eastern India.
    Hasanoor Reja AH; Biswas N; Biswas S; Lavania M; Chaitanya VS; Banerjee S; Maha Patra PS; Gupta UD; Patra PK; Sengupta U; Bhattacharya B
    Indian J Dermatol Venereol Leprol; 2015; 81(2):155-61. PubMed ID: 25751332
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Leprosy at a turning point?
    Harboe M
    Int J Lepr Other Mycobact Dis; 2000 Sep; 68(3):312-8. PubMed ID: 11221095
    [No Abstract]   [Full Text] [Related]  

  • 34. qPCR-High resolution melt analysis for drug susceptibility testing of Mycobacterium leprae directly from clinical specimens of leprosy patients.
    Araujo S; Goulart LR; Truman RW; Goulart IMB; Vissa V; Li W; Matsuoka M; Suffys P; Fontes AB; Rosa PS; Scollard DM; Williams DL
    PLoS Negl Trop Dis; 2017 Jun; 11(6):e0005506. PubMed ID: 28570560
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical and bacteriological effects of rifampicin in combination with L73A in leprosy: observation for six months.
    Innami S; Leguizamón OR; Alvarenga AE
    Lepr Rev; 1975 Jun; 46(2 Suppl):169-72. PubMed ID: 1100957
    [No Abstract]   [Full Text] [Related]  

  • 36. Evolution of the modern chemotherapy of leprosy.
    Levy L
    Lepr Rev; 1983 Jun; Spec No():69-83. PubMed ID: 6350773
    [No Abstract]   [Full Text] [Related]  

  • 37. Resistance to anti leprosy drugs in multi-bacillary leprosy: A cross sectional study from a tertiary care centre in eastern Uttar Pradesh, India.
    Singh SK; Kumar A; Nath G; Singh TB; Mishra MN
    Indian J Dermatol Venereol Leprol; 2018; 84(3):275-279. PubMed ID: 29536982
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recent trends in chemotherapy of leprosy.
    Parikh DA; Maniar JK; Parikh AC; Ganapati R
    J Assoc Physicians India; 1985 Sep; 33(9):593-5. PubMed ID: 3912375
    [No Abstract]   [Full Text] [Related]  

  • 39. Drug resistance patterns in Mycobacterium leprae isolates from relapsed leprosy patients attending The Leprosy Mission (TLM) Hospitals in India.
    Lavania M; Jadhav RS; Chaitanya VS; Turankar R; Selvasekhar A; Das L; Darlong F; Hambroom UK; Kumar S; Sengupta U
    Lepr Rev; 2014 Sep; 85(3):177-85. PubMed ID: 25509718
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Discovery of a potential lead compound for treating leprosy with dapsone resistance mutation in M. leprae folP1.
    Nisha J; Ramanathan K; Nawaz Khan F; Dhanasekaran D; Shanthi V
    Mol Biosyst; 2016 Jun; 12(7):2178-88. PubMed ID: 27120972
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.